TECELRA Receives Full FDA Approval, Expands Access to Adolescents with Synovial Sarcoma
US WorldMeds® announced that the U.S. Food and Drug Administration has granted full approval to TECELRA® (afamitresgene autoleucel), with an expanded indication that now includes eligible patients as young as 12 years old. The therapy, which received its original accelerated approval in August 2024, remains…
11 Leading Oncologists and Researchers Unite to Accelerate Progress for Synovial Sarcoma Patients PHILADELPHIA [June 22, 2026] The Synovial Sarcoma Foundation (SSF) today announced the formation of its Medical Advisory Board, bringing together 11 internationally recognized clinicians and researchers to serve as the central coordinating…
Breaking Down Synovial Sarcoma’s Defenses: A study on Immune Evasion and Targeted Treatment
A landmark study from Jerby-Arnon, Neftel, Shore, and colleagues at the Broad Institute of Harvard and MIT, Massachusetts General Hospital, Dana-Farber Cancer Institute, and the University of Lausanne used single-cell RNA sequencing to profile 16,872 individual cells from 12 human synovial sarcoma tumors – one…
Synovial Sarcoma Foundation Wins First Place at the 16th Annual SPAGN Conference
We are incredibly honored to share that the Synovial Sarcoma Foundation received First Place in the Advocacy in Action Award…
Synovial Sarcoma Foundation Welcomes Lucia and Roberto Belluco to the Board of Directors
[Philadelphia, PA] The Synovial Sarcoma Foundation (SSF) is honored to welcome Lucia Manzinello Belluco and Roberto Belluco to its Board…
Synovial Sarcoma Research and Rare Cancer Drug Development: Challenges and Progress
Developing treatments for rare cancers like synovial sarcoma remains one of the biggest challenges in modern medicine—but recent progress shows…
New Research Identifies 4 Subtypes of Synovial Sarcoma, Opening Doors for Personalized Treatment
Synovial sarcoma is a rare and aggressive soft tissue cancer, but new research is helping us better understand how it…
What a Breakthrough in Ewing Sarcoma Means for Synovial Sarcoma
A new Phase 1/2 trial in Ewing sarcoma, just profiled in Clinical Trial Vanguard and published in Nature Medicine, delivered…
Rare Tumor Mimics Synovial Sarcoma: Why Accurate Diagnosis Matters
A recent case report highlights a rare GLI1-altered mesenchymal tumor presenting in the pleura (lining of the lung), a location…
Cell Therapies for Synovial Sarcoma: Afami-cel (Tecelra)
Advances in cell therapy for synovial sarcoma are creating more treatment options for patients with advanced disease. A recent update…
Synovial Sarcoma Around the Heart: Rare Case Highlights Importance of Early Diagnosis
Synovial sarcoma is a rare soft tissue cancer that usually develops near joints in the arms or legs. However, in…
Primary Cardiac Synovial Sarcoma: A Rare and Challenging Diagnosis
Synovial sarcoma is a rare soft tissue cancer that most commonly develops near the joints of the arms or legs.…
